TY - JOUR T1 - Updates in the management of cranial dural arteriovenous fistula JF - Stroke and Vascular Neurology JO - Stroke Vasc Neurol SP - 50 LP - 58 DO - 10.1136/svn-2019-000269 VL - 5 IS - 1 AU - Humain Baharvahdat AU - Yinn Cher Ooi AU - Wi Jin Kim AU - Ashkan Mowla AU - Alexander L Coon AU - Geoffrey P Colby Y1 - 2020/03/01 UR - http://svn.bmj.com/content/5/1/50.abstract N2 - Dural arteriovenous fistula (dAVF) accounts for approximately 10% of all intracranial vascular malformations. While they can be benign lesions, the presence of retrograde venous drainage and cortical venous reflux makes the natural course of these lesions aggressive high risk of haemorrhage, neurological injury and mortality. Endovascular treatment is often the first line of treatment for dAVF. Both transarterial and transvenous approaches are used to cure dAVF. The selection of treatment approach depends on the angioarchitecture of the dAVF, the location, the direction of venous flow. Surgery and, to a lesser extent, stereotactic radiosurgery are used when endovascular approaches are impossible or unsuccessful. ER -